Foley Attorneys File Amicus Brief Related to ACLU v. Myriad

11 January 2010 Media Contact: Jill Chanen News
Foley attorneys filed an amicus brief in the United States District Court for the Southern District of New York related to ACLU v. Myriad regarding subject matter patentability of gene patents specifically on isolated DNA. The authors conclude that the U.S. Congress, U.S. courts and the USPTO, as well as the scientific community and biotechnology industry have long relied upon an understanding that claims directed to "isolated DNA" recite patentable subject matter under 35 U.S.C. §101 and the Constitution. The authors maintain that to hold otherwise would have a dramatic negative effect on biotech research as we know it, and will influence the entire business of biotechnology in ways unforeseen or addressed by the plaintiffs in ACLU v. Myriad"

Insights

Voting in the Age of COVID-19
26 October 2020
Coronavirus Resource Center:Back to Business
401(k) Fee Lawsuits: What Can a Plan Sponsor Do?
26 October 2020
Labor & Employment Law Perspectives
Department of Defense Formally Implements Cybersecurity Maturity Model Certification Requirements for Department of Defense Contractors
26 October 2020
Legal News: Government Procurement
FinCEN Takes Action Against Bitcoin Mixer for Violating the Bank Secrecy Act
26 October 2020
Legal News: Government Enforcement Defense & Investigations